LSB Industries, Inc. Reports Record Operating Results for the 2022 Second Quarter
Achieves All-Time Highest Quarterly EBITDA in Company History
Second Quarter 2022 Highlights
-
Net sales of
$284.8 million compared to$140.7 million in the second quarter of 2021 -
Adjusted EBITDA(1) of
$158.1 million compared to$46.0 million in the second quarter of 2021 - Adjusted EBITDA(1) margin of 55.5% compared to 32.7% in the second quarter of 2021
-
Adjusted EPS(1) of
$1.22 in the second quarter of 2022 -
Cash Flow from Operations of
$135.3 million and Capital Expenditures of$8.2 million -
Total liquidity of over
$500 million as ofJune 30, 2022 -
Authorized and commenced share repurchases under a
$50 million buyback program - Announced feasibility study for a green ammonia project at Pryor Facility
“We had another quarter of record results with significant year-over-year growth in net sales, adjusted EBITDA and EPS,” stated
______________________ |
(1) This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section |
Second Quarter Results Overview
Three Months Ended |
|||||
Product (Gross Sales) |
2022 |
2021 |
% Change |
||
AN & Nitric Acid |
|
|
69% |
||
Urea ammonium nitrate (UAN) |
76,986 |
29,899 |
157% |
||
Ammonia |
89,444 |
38,541 |
132% |
||
Other |
22,231 |
15,517 |
43% |
||
|
|
102% |
Comparison of 2022 to 2021 quarterly periods:
-
Net sales increased during the quarter driven by stronger pricing for all of our products for sales made at both spot pricing as well as those related to a rise in the
Tampa ammonia benchmark price, to which many of our contracts are tied. The benefit of stronger pricing was partially offset by lower sales volumes due, in part, to the impact of wet weather in certain areas of theU.S. , and dry conditions in other areas, on fertilizer purchases by farmers.
- The year-over-year improvement in operating income and adjusted EBITDA primarily resulted from higher selling prices, partially offset by higher natural gas feedstock prices and lower sales volumes.
The following tables provide key sales metrics for our products:
|
|
Three Months Ended |
|||||
Key Product Volumes (short tons sold) |
|
2022 |
|
2021 |
|
% Change |
|
AN & Nitric Acid |
|
162,014 |
|
186,962 |
|
(13 |
) % |
Urea ammonium nitrate (UAN) |
|
130,561 |
|
121,995 |
|
7 |
% |
Ammonia |
|
75,526 |
|
84,540 |
|
(11 |
) % |
|
|
368,101 |
|
393,497 |
|
(6 |
) % |
Average Selling Prices (price per short ton) (A) |
|
|
|
|
|
|
|||
AN & Nitric Acid |
|
$ |
525 |
|
$ |
259 |
|
103 |
% |
Urea ammonium nitrate (UAN) |
|
$ |
553 |
|
$ |
231 |
|
139 |
% |
Ammonia |
|
$ |
1,164 |
|
$ |
441 |
|
164 |
% |
(A) Average selling prices represent “net back” prices which are calculated as sales less freight expenses divided by product sales volume in tons. |
|
|
Three Months Ended |
|||||||
|
|
2022 |
|
2021 |
|
% Change |
|||
Average Benchmark Prices (price per ton) |
|
|
|
|
|
|
|||
Tampa Ammonia (MT) Benchmark |
|
$ |
1,257 |
|
$ |
545 |
|
131 |
% |
UAN Southern Plains |
|
$ |
612 |
|
$ |
342 |
|
79 |
% |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
Input Costs |
|
|
|
|
|
|
|||
Average natural gas cost/MMBtu |
|
$ |
7.15 |
|
$ |
2.78 |
|
157 |
% |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Financial Position and Capital Expenditures
As of
Interest expense for the both the second quarter of 2022 and 2021 was
During the second quarter we repurchased approximately
Capital expenditures were approximately
Outlook
A variety of factors suggest that demand for fertilizers should continue to be robust, and fertilizer pricing should remain above historical averages for the rest of 2022, and full year 2023. The
Domestic natural gas prices are well above where they were at this time a year ago. However, selling prices for our products have increased by a significant multiple of the increase in gas cost over the same period. We expect this to translate into continued strong margins over the course of 2022 and likely throughout 2023. Natural gas costs in
Significantly exacerbating the aforementioned factors contributing to increased corn and fertilizer prices is the impact of the Russian invasion of
Sales volumes for our industrial business have remained stable despite weakening forecasts for economic growth. Demand for nitric acid, a product with a broad range of applications, continues to be strong and our large long-term nitric acid contract helps protect us on the downside in the event that some end markets are impacted by a potential recession. Pricing for our industrial sales remains well above year ago levels, reflecting competition from fertilizer demand and other nitrogen demand and the continued strength in the
Conference Call
LSB’s management will host a conference call covering the second quarter results on
To listen to a webcast of the call, please go to the Company’s website at www.lsbindustries.com at least 15 minutes prior to the conference call to download and install any necessary audio software. If you are unable to listen live, the conference call webcast will be archived on the Company’s website.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
See Accompanying Tables
Condensed Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
(In Thousands, Except Per Share Amounts) |
||||||||||||||
Net sales |
|
$ |
284,803 |
|
|
$ |
140,696 |
|
|
$ |
483,784 |
|
|
$ |
238,812 |
|
Cost of sales |
|
|
141,879 |
|
|
|
105,688 |
|
|
|
250,130 |
|
|
|
195,744 |
|
Gross profit |
|
|
142,924 |
|
|
|
35,008 |
|
|
|
233,654 |
|
|
|
43,068 |
|
|
|
|
|
|
|
|
|
|
||||||||
Selling, general and administrative expense |
|
|
9,638 |
|
|
|
8,545 |
|
|
|
20,573 |
|
|
|
17,338 |
|
Other expense (income), net |
|
|
628 |
|
|
|
6 |
|
|
|
452 |
|
|
|
(257 |
) |
Operating income |
|
|
132,658 |
|
|
|
26,457 |
|
|
|
212,629 |
|
|
|
25,987 |
|
|
|
|
|
|
|
|
|
|
||||||||
Interest expense, net |
|
|
12,307 |
|
|
|
12,290 |
|
|
|
22,262 |
|
|
|
24,662 |
|
Loss (gain) on extinguishment of debt |
|
|
— |
|
|
|
(10,000 |
) |
|
|
113 |
|
|
|
(10,000 |
) |
Non-operating other expense (income), net |
|
|
(3,430 |
) |
|
|
745 |
|
|
|
(3,408 |
) |
|
|
1,140 |
|
Income before provision (benefit) for income taxes |
|
|
123,781 |
|
|
|
23,422 |
|
|
|
193,662 |
|
|
|
10,185 |
|
Provision (benefit) for income taxes |
|
|
20,382 |
|
|
|
(248 |
) |
|
|
31,497 |
|
|
|
(206 |
) |
Net income |
|
|
103,399 |
|
|
|
23,670 |
|
|
|
162,165 |
|
|
|
10,391 |
|
|
|
|
|
|
|
|
|
|
||||||||
Dividends on convertible preferred stocks |
|
|
— |
|
|
|
75 |
|
|
|
— |
|
|
|
150 |
|
Dividends on Series E redeemable preferred stock |
|
|
— |
|
|
|
10,213 |
|
|
|
— |
|
|
|
19,724 |
|
Accretion of Series E redeemable preferred stock |
|
|
— |
|
|
|
513 |
|
|
|
— |
|
|
|
1,024 |
|
Net income attributable to participating securities |
|
|
— |
|
|
|
223 |
|
|
|
— |
|
|
|
— |
|
Net income (loss) attributable to common stockholders |
|
$ |
103,399 |
|
|
$ |
12,646 |
|
|
$ |
162,165 |
|
|
$ |
(10,507 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Net income (loss) |
|
$ |
1.17 |
|
|
$ |
0.34 |
|
|
$ |
1.84 |
|
|
$ |
(0.28 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Net income (loss) |
|
$ |
1.15 |
|
|
$ |
0.32 |
|
|
$ |
1.81 |
|
|
$ |
(0.28 |
) |
Adjusted Net Income and Adjusted EPS (1) |
|
|
|
|||||||||||
Adjusted net income attributable to common stockholders |
|
$ |
103,399 |
|
$ |
23,372 |
|
$ |
162,165 |
|
|
$ |
10,241 |
|
Other adjustments |
|
|
5,782 |
|
|
3,018 |
|
|
9,413 |
|
|
|
4,071 |
|
Adjusted net income |
|
$ |
109,181 |
|
$ |
26,390 |
|
$ |
171,578 |
|
|
$ |
14,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income per common share excluding other adjustments (1) |
|
$ |
1.22 |
|
$ |
0.67 |
|
$ |
1.91 |
|
|
$ |
0.37 |
|
________________________________ | ||||||||||||||
(1) This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section |
Consolidated Balance Sheets
(Information at |
||||||||
|
|
|
|
|
|
|
||
|
|
2022 |
|
|
2021 |
|
||
|
|
(In Thousands) |
|
|||||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
125,231 |
|
|
$ |
82,144 |
|
Short-term investments |
|
|
325,566 |
|
|
|
— |
|
Accounts receivable |
|
|
97,406 |
|
|
|
86,902 |
|
Allowance for doubtful accounts |
|
|
(652 |
) |
|
|
(474 |
) |
Accounts receivable, net |
|
|
96,754 |
|
|
|
86,428 |
|
Inventories: |
|
|
|
|
|
|
|
|
Finished goods |
|
|
34,144 |
|
|
|
14,688 |
|
Raw materials |
|
|
1,831 |
|
|
|
1,895 |
|
Total inventories |
|
|
35,975 |
|
|
|
16,583 |
|
Supplies, prepaid items and other: |
|
|
|
|
|
|
|
|
Prepaid insurance |
|
|
6,174 |
|
|
|
14,244 |
|
Precious metals |
|
|
13,929 |
|
|
|
14,945 |
|
Supplies |
|
|
27,263 |
|
|
|
26,558 |
|
Other |
|
|
7,134 |
|
|
|
2,234 |
|
Total supplies, prepaid items and other |
|
|
54,500 |
|
|
|
57,981 |
|
Total current assets |
|
|
638,026 |
|
|
|
243,136 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
839,411 |
|
|
|
858,480 |
|
|
|
|
|
|
|
|
|
|
Other assets: |
|
|
|
|
|
|
|
|
Operating lease assets |
|
|
27,056 |
|
|
|
27,317 |
|
Intangible and other assets, net |
|
|
3,221 |
|
|
|
3,907 |
|
|
|
|
30,277 |
|
|
|
31,224 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,507,714 |
|
|
$ |
1,132,840 |
|
Consolidated Balance Sheets (continued)
(Information at |
||||||||
|
|
|
|
|
|
|
||
|
|
2022 |
|
|
2021 |
|
||
|
|
(In Thousands) |
|
|||||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
69,308 |
|
|
$ |
49,458 |
|
Short-term financing |
|
|
5,682 |
|
|
|
12,716 |
|
Accrued and other liabilities |
|
|
31,325 |
|
|
|
33,301 |
|
Current portion of long-term debt |
|
|
10,977 |
|
|
|
9,454 |
|
Total current liabilities |
|
|
117,292 |
|
|
|
104,929 |
|
|
|
|
|
|
|
|
|
|
Long-term debt, net |
|
|
704,427 |
|
|
|
518,190 |
|
|
|
|
|
|
|
|
|
|
Noncurrent operating lease liabilities |
|
|
18,681 |
|
|
|
19,568 |
|
|
|
|
|
|
|
|
|
|
Other noncurrent accrued and other liabilities |
|
|
523 |
|
|
|
3,030 |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
57,232 |
|
|
|
26,633 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
9,117 |
|
|
|
9,117 |
|
Capital in excess of par value |
|
|
495,330 |
|
|
|
493,161 |
|
Retained earnings (accumulated deficit) |
|
|
130,910 |
|
|
|
(31,255 |
) |
|
|
|
635,357 |
|
|
|
471,023 |
|
Less treasury stock, at cost: |
|
|
|
|
|
|
|
|
Common stock, 2.3 million shares (1.4 million shares at
|
|
|
25,798 |
|
|
|
10,533 |
|
Total stockholders' equity |
|
|
609,559 |
|
|
|
460,490 |
|
|
|
$ |
1,507,714 |
|
|
$ |
1,132,840 |
|
Non-GAAP Reconciliations
This news release includes certain “non-GAAP financial measures” under the rules of the
EBITDA and Adjusted EBITDA Reconciliation
EBITDA is defined as net income (loss) plus interest expense, less gain (loss) on extinguishment of debt, plus depreciation and amortization (D&A) (which includes D&A of property, plant and equipment and amortization of intangible and other assets), plus provision (benefit) for income taxes. Adjusted EBITDA is reported to show the impact of non-cash stock-based compensation, one time/non-cash or non-operating items-such as, one-time income or fees, loss (gain) on sale of a business and/or other property and equipment, certain fair market value (FMV) adjustments, and consulting costs associated with reliability and purchasing initiatives (Initiatives). We historically have performed Turnaround activities on an annual basis; however, we have moved towards extending Turnarounds to a two or three-year cycle. Rather than being capitalized and amortized over the period of benefit, our accounting policy is to recognize the costs as incurred. Given these Turnarounds are essentially investments that provide benefits over multiple years, they are not reflective of our operating performance in a given year.
We believe that certain investors consider EBITDA a useful means of measuring our ability to meet our debt service obligations and evaluating our financial performance. In addition, we believe that certain investors consider adjusted EBITDA as more meaningful to further assess our performance. We believe that the inclusion of supplementary adjustments to EBITDA is appropriate to provide additional information to investors about certain items.
EBITDA and adjusted EBITDA have limitations and should not be considered in isolation or as a substitute for net income, operating income, cash flow from operations or other consolidated income or cash flow data prepared in accordance with GAAP. Because not all companies use identical calculations, this presentation of EBITDA and adjusted EBITDA may not be comparable to a similarly titled measure of other companies. The following table provides a reconciliation of net income (loss) to EBITDA and adjusted EBITDA for the periods indicated. Adjusted EBITDA margin is calculated by taking adjusted EBITDA divided by
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per share have been adjusted for the impact of the closing of the Exchange Transaction on
Non-GAAP Reconciliations (continued) |
||||||||||||
LSB Consolidated ($ In Thousands) |
Three Months Ended
|
Six Months Ended
|
||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||
Net income |
$ |
103,399 |
$ |
23,670 |
|
$ |
162,165 |
$ |
10,391 |
|||
Plus: |
||||||||||||
Interest expense, net |
|
11,584 |
|
12,290 |
|
|
21,539 |
|
24,662 |
|||
Loss (gain) on extinguishment of debt |
|
- |
|
(10,000 |
) |
|
113 |
|
(10,000) |
|||
Depreciation and amortization |
|
16,996 |
|
17,277 |
|
|
34,504 |
|
34,354 |
|||
Provision (benefit) for income taxes |
|
20,382 |
|
(248 |
) |
|
31,497 |
|
(206) |
|||
EBITDA |
$ |
152,361 |
$ |
42,989 |
|
$ |
249,818 |
$ |
59,201 |
|||
Stock-based compensation |
|
1,365 |
|
1,063 |
|
|
2,168 |
|
1,776 |
|||
Noncash (gain) on natural gas contracts |
|
- |
|
- |
|
|
- |
|
(1,205) |
|||
Legal fees (Leidos) |
|
270 |
|
441 |
|
|
613 |
|
1,327 |
|||
Loss on disposal of assets |
|
852 |
|
91 |
|
|
806 |
|
174 |
|||
Fair market value adjustment on preferred stock embedded derivatives |
|
- |
|
716 |
|
|
- |
|
1,152 |
|||
Turnaround costs |
|
3,295 |
|
707 |
|
|
5,826 |
|
847 |
|||
Adjusted EBITDA |
$ |
158,143 |
$ |
46,007 |
|
$ |
259,231 |
$ |
63,272 |
Non-GAAP Reconciliations (continued) |
|||||||||||||
|
Three Months Ended
|
|
|
Six Months Ended
|
|||||||||
2022 |
|
2021 |
|
|
2022 |
|
2021 |
||||||
|
(In Thousands, Except Per Share Amounts) |
||||||||||||
Numerator: |
|
|
|
|
|
|
|
|
|||||
Net income (loss) attributable to common stockholders |
$ |
103,399 |
|
$ |
12,646 |
|
|
$ |
162,165 |
|
$ |
(10,507 |
) |
Adjustments: |
|
|
|
|
|
|
|
|
|||||
Dividend requirements on Series E Redeemable Preferred |
|
- |
|
|
10,213 |
|
|
|
- |
|
|
19,724 |
|
Accretion of Series E Redeemable Preferred |
|
- |
|
|
513 |
|
|
|
- |
|
|
1,024 |
|
Adjusted net income (loss) attributable to common stockholders |
|
103,399 |
|
|
23,372 |
|
|
|
162,165 |
|
|
10,241 |
|
Other Adjustments: |
|
|
|
|
|
|
|
|
|||||
Stock-based compensation |
|
1,365 |
|
|
1,063 |
|
|
|
2,168 |
|
|
1,776 |
|
Noncash loss (gain) on natural gas contracts |
|
- |
|
|
- |
|
|
|
- |
|
|
(1,205 |
) |
Legal fees (Leidos) |
|
270 |
|
|
441 |
|
|
|
613 |
|
|
1,327 |
|
Loss on disposal of assets |
|
852 |
|
|
91 |
|
|
|
806 |
|
|
174 |
|
Fair market value adjustment on preferred stock embedded derivative |
|
- |
|
|
716 |
|
|
|
- |
|
|
1,152 |
|
Turnaround costs |
|
3,295 |
|
|
707 |
|
|
|
5,826 |
|
|
847 |
|
Adjusted net income (loss) attributable to common stockholders, excluding other adjustments |
$ |
109,181 |
|
$ |
26,390 |
|
|
$ |
171,578 |
|
$ |
14,312 |
|
Denominator: |
|
|
|
|
|
|
|
|
|||||
Adjusted weighted-average shares for basic net income (loss) per share and for adjusted net income (loss) per share (1) |
|
88,181 |
|
|
37,031 |
|
|
|
88,301 |
|
|
37,162 |
|
Adjustment: |
|
|
|
|
|
|
|
|
|||||
Unweighted shares, including unvested restricted stock subject to forfeiture |
|
1,224 |
|
|
2,199 |
|
|
|
1,458 |
|
|
1,665 |
|
Outstanding shares, net of treasury, at period end for adjusted net income (loss) per share, excluding other adjustments |
|
89,405 |
|
|
39,230 |
|
|
|
89,759 |
|
|
38,827 |
|
|
|
|
|
|
|
|
|
||||||
Basic net income (loss) per common share |
$ |
1.17 |
|
$ |
0.34 |
|
|
$ |
1.84 |
|
$ |
(0.28 |
) |
|
|
|
|
|
|
|
|
||||||
Adjusted net income (loss) per common share, excluding other adjustments |
$ |
1.22 |
|
$ |
0.67 |
|
|
$ |
1.91 |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
||||||
(1) Excludes the weighted-average shares of unvested restricted stock that are subject to forfeiture |
Ammonia, AN, UAN Sales Price Reconciliation
The following table provides a reconciliation of total identified net sales as reported under GAAP in our consolidated financial statements reconciled to netback sales which is calculated as net sales less freight and other non-netback costs. We believe this provides a relevant industry comparison among our peer group.
Three Months Ended
|
||||||
2022 |
2021 |
|||||
(In Thousands) |
||||||
Ammonia, AN, Nitric Acid, UAN Net sales |
$ |
262,572 |
$ |
125,179 |
||
|
|
|
||||
Less freight and other |
|
17,424 |
|
11,332 |
||
|
|
|
||||
Ammonia, AN, UAN netback sales |
$ |
245,148 |
$ |
113,847 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005928/en/
(405) 510-3524
(405) 510-3550
fbuonocore@lsbindustries.com
Source: